Steven Richieri has more than 25 years of experience in the health care industry and has a broad background in biotechnology, pharmaceutical, and medical device product development and research. He also has extensive experience in the US Food and Drug Administration’s regulatory process and has been responsible for taking a number of products from the research laboratory to the clinic for stroke, HIV, autoimmune diseases, cancer, and allergic rhinitis. Mr. Richieri has held senior executive positions at PhotoThera, Inc., Egea Biosciences, Inc. (a wholly owned subsidiary of Centocor Inc.), The Immune Response Corporation and Dura Pharmaceuticals. He is also the co-founder of American Life Science Pharmaceuticals, a start-up drug discovery company focused on finding novel therapeutics to treat neurodegenerative and age-related disorders and NuVista Technology Corporation, a privately held medical device company. Mr. Richieri received a B.S. in Pharmacy from Rutgers College of Pharmacy in 1977 and a MBA from the University of San Diego in 1983.